Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1983 Feb 12;286(6364):499–500. doi: 10.1136/bmj.286.6364.499

Pneumocystis pneumonia.

S B Kaye
PMCID: PMC1546608  PMID: 6402123

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAAR H. S. Interstitial plasmacellular pneumonia due to Pneumocystis carinii. J Clin Pathol. 1955 Feb;8(1):19–24. doi: 10.1136/jcp.8.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brennan R. O., Durack D. T. Gay compromise syndrome. Lancet. 1981 Dec 12;2(8259):1338–1339. doi: 10.1016/s0140-6736(81)91352-0. [DOI] [PubMed] [Google Scholar]
  3. Hasleton P. S., Curry A. Pneumocystis carinii: the continuing enigma. Thorax. 1982 Jul;37(7):481–485. doi: 10.1136/thx.37.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hughes W. T., Feldman S., Chaudhary S. C., Ossi M. J., Cox F., Sanyal S. K. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr. 1978 Feb;92(2):285–291. doi: 10.1016/s0022-3476(78)80028-6. [DOI] [PubMed] [Google Scholar]
  5. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  6. Hughes W. T. Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii. Antimicrob Agents Chemother. 1979 Sep;16(3):333–335. doi: 10.1128/aac.16.3.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Masur H., Michelis M. A., Wormser G. P., Lewin S., Gold J., Tapper M. L., Giron J., Lerner C. W., Armstrong D., Setia U. Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med. 1982 Oct;97(4):533–539. doi: 10.7326/0003-4819-97-4-533. [DOI] [PubMed] [Google Scholar]
  8. Pifer L. L., Hughes W. T., Stagno S., Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics. 1978 Jan;61(1):35–41. [PubMed] [Google Scholar]
  9. Pifer L. L., Woods D., Hughes W. T. Propagation of Pneumocystis carinii in Vero cell culture. Infect Immun. 1978 Apr;20(1):66–68. doi: 10.1128/iai.20.1.66-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sattler F. R., Remington J. S. Intravenous trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonia. Am J Med. 1981 Jun;70(6):1215–1221. doi: 10.1016/0002-9343(81)90830-5. [DOI] [PubMed] [Google Scholar]
  11. Walzer P. D., Perl D. P., Krogstad D. J., Rawson P. G., Schultz M. G. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974 Jan;80(1):83–93. doi: 10.7326/0003-4819-80-1-83. [DOI] [PubMed] [Google Scholar]
  12. du Bois R. M., Branthwaite M. A., Mikhail J. R., Batten J. C. Primary Pneumocystis carinii and cytomegalovirus infections. Lancet. 1981 Dec 12;2(8259):1339–1339. doi: 10.1016/s0140-6736(81)91353-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES